Related Experiment Video
Updated: Jun 15, 2026
11:15
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Lung cancer in 'Never-smokers': a unique entity
Janakiraman Subramanian1, Ramaswamy Govindan
1Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Oncology (Williston Park, N.Y.)
|March 2, 2010
Summary
Lung cancer in never-smokers shows better outcomes with epidermal growth factor receptor-tyrosine kinase (EGFR-TK) inhibitors. Unique molecular changes in these patients offer potential for novel lung cancer treatments.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Lung cancer in never-smokers represents a distinct clinical and molecular subgroup.
- This population has historically been understudied compared to smokers.
- Recent advances highlight unique biological characteristics and treatment responses.
Purpose of the Study:
- To review current knowledge on lung cancer in never-smokers.
- To explore the molecular differences and treatment implications.
- To identify potential avenues for future research and therapeutic development.
Main Methods:
- Literature review of existing studies on never-smoker lung cancer.
- Analysis of molecular profiles and treatment outcomes.
- Synthesis of data on epidermal growth factor receptor-tyrosine kinase (EGFR-TK) inhibitor efficacy.
Main Results:
- Never-smoker lung cancer patients exhibit improved responses to EGFR-TK inhibitors.
- Distinct molecular alterations are identified in lung tumors of never-smokers.
- These findings suggest unique oncogenic pathways in this patient group.
Conclusions:
- Lung cancer in never-smokers is biologically unique and warrants specific research focus.
- Targeted therapies, particularly EGFR-TK inhibitors, show promise.
- Further investigation into unique molecular drivers may lead to novel lung cancer therapies.
Related Concept Videos
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.